Identifying the ceRNA Regulatory Network in Early-Stage Acute Pancreatitis and Investigating the Therapeutic Potential of NEAT1 in Mouse Models
Bi Lin,Chaohao Huang
DOI: https://doi.org/10.2147/jir.s490315
IF: 4.5
2024-11-03
Journal of Inflammation Research
Abstract:Bi Lin, 1 Chaohao Huang 2 1 Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China; 2 Department of Hepatological Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China Correspondence: Chaohao Huang, Department of Hepatological Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, People's Republic of China, Email Purpose: Acute pancreatitis (AP) is a common digestive disorder characterized by high morbidity and mortality. This study aims to uncover differentially expressed long noncoding RNAs (lncRNAs) and mRNAs, as well as related pathways, in the early stage of acute pancreatitis (AP), with a focus on the role of Neat1 in AP and severe acute pancreatitis (SAP). Methods: In this study, we performed high-throughput RNA sequencing on pancreatic tissue samples from three normal mice and three mice with cerulein-induced AP to describe and analyze the expression profiles of long non-coding RNAs (lncRNAs) and mRNAs. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were conducted on the differentially expressed mRNAs to identify enriched pathways and biological processes. An lncRNA-miRNA-mRNA interaction network was constructed to elucidate potential regulatory mechanisms. Furthermore, we utilized Neat1 knockout mice to investigate the role of Neat1 in the pathogenesis of cerulein-AP and L-arginine-severe acute pancreatitis (SAP). Results: Our results revealed that 261 lncRNAs and 1522 mRNAs were differentially expressed in the cerulein-AP group compared to the control group. GO and KEGG analyses of the differentially expressed mRNAs indicated that the functions of the corresponding genes are enriched in cellular metabolism, intercellular structure, and positive regulation of inflammation, which are closely related to the central events in the pathogenesis of AP. A ceRNA network involving 5 lncRNAs, 226 mRNAs, and 61 miRNAs were constructed. Neat1 was identified to have the potential therapeutic effects in AP. Neat1 knockout in mice inhibited pyroptosis in both the AP/SAP mouse models. Conclusion: We found that lncRNAs, particularly Neat1, play a significant role in the pathogenesis of AP. This finding may provide new insights into further exploring the pathogenesis of SAP and could lead to the identification of new targets for the treatment of AP and SAP. Keywords: acute pancreatitis, lncRNA, ceRNA, NEAT1, pyroptosis Acute pancreatitis (AP) is a disease characterized by the pancreas essentially digesting itself, triggered by the activation of trypsin due to a variety of causes. 1 It is a significant health concern, being one of the primary reasons for hospital admissions related to gastrointestinal issues. 2,3 Of those diagnosed with AP, about 20% may experience a progression to severe acute pancreatitis (SAP), which is accompanied by local or systemic complications and often requires invasive interventions. This can drive the mortality rate for SAP as high as 30%. 4,5 Current therapies for acute pancreatitis (AP) are largely non-specific and supportive in nature, a necessity given the disease's potential for rapid and unpredictable fluctuations in severity and clinical progression. 6 Hence, it is crucial to explore these molecular mechanisms and identify potential biomarkers and novel therapeutic targets. Accumulating body of research indicates that non-coding RNAs (ncRNAs), such as long noncoding RNAs (lncRNAs), circular RNAs (circRNAs), and microRNAs (miRNAs), play a significant role in the onset and progression of numerous diseases. These include lung cancer, 7 inflammatory bowel disease, 8 cancer resistance, 9 cardiovascular disease 10 and pancreatic disorders, among others. Furthermore, the expression of ncRNAs is tightly regulated under normal physiological conditions. 11 Therefore, altered expression of ncRNAs could potentially serve as diagnostic biomarkers or therapeutic targets for diseases. Studies have revealed that certain lncRNAs are implicated in the pathophysiological mechanisms of acute pancreatitis (AP), participating in various processes such as the regulation of macrophage polarization, 12 the preservation of gastrointestinal motility dysfunction, 13 and and the induction of pancreatitis-associated lung injury. 14 For example, during the inflammatory response in AP, lncRNAs primarily modulate the NF-κB pathway either directly or indirectly, triggering the expression and secretion of inflammatory factors and promoting M1 macrophage polarization. LncRNA Fendr -Abstract Truncated-
immunology